Диагностика и лечение опухолей яичника: Литература
СтатьиОпубликовано в монографии А.Ф. Урманчеева, Г.Ф. Кутушева
ЛИТЕРАТУРА
1. Бохман Я. В. Руководство по онкогинекологии. —Л., 1989. —464 с.
2. Верморкен Я. Эпителиальный рак яичников: состояние проблемы // Материалы Второй ежегодной российской онкологической конференции. — М., 1999. — С. 85-88.
3. Веснин А. Г., Новик В. И., Мешкова И. Е., Красильникова Л. А. Комплексная лучевая и цитологическая диагностика злокачественных опухолей женских половых органов: Пособие для врачей. — СПб.: Б. и., 1999. — 24 с.
4. Злокачественные новообразования в России в 1998 году (заболеваемость и смертность) / Под. ред. акад. В. И. Чиссова, проф. В. В. Старинского, к. м. н. Л. В. Ременник. — М., 2000. — 284 с.
5. Колосов А. Е. Опухоли яичников и прогноз для больных. — Киров, 1996. — 240 с.
6. Маккэй Д. Клиническое применение последних открытий в генетике рака // Материалы Второй ежегодной российской онкологической конференции. — М., 1999. — С. 39-42.
7. Мерабишвили В. М., Попова С. П., Урманчеева А. Ф. и др. Анализ онкогинекологической заболеваемости и оценка эффективности лечения злокачественных опухолей женских гениталий в Санкт-Петербурге // Вопр. онкологии. — 1999. — № 3. — С. 233-238.
8. Нечаева И. Д. Опухоли яичников. — Л.: Медицина, 1987. — 208 с.
9. Новикова Е. Г., Ронина Е. А. Особенности эпидемиологии и современные методы диагностики злокачественных опухолей яичников // Гинекология. — 1999. — № 2. — С. 42-44.
10. Тюляндин С. А. Выбор химиотерапии первой линии у больных распространенным раком яичника//Вопр. онкологии. — 1999. —№4. —С. 350-354.
11. Тюляндин С. А. Рак яичников. — М., 1996. — 63 с.
12. Урманчеева А. Ф., Бурнина М. М. Заместительная гормонотерапия и злокачественные опухоли // Журн. акуш. и жен. болезней. — 2000. — № 1. — С. 58-62.
13. Цыпурдеева А. А., Урманчеева А. Ф., Зельдович Д. Р. Роль лапароскопии в диагностике и лечении рака яичников // Вопр. онкологии. — 2000. — № 1. — С. 76-80.
14. Ayhan A., Tuncer Z. S., Tuncer R., Mercar R., Yuce K. Granulosa cell tumors of the ovary: a clinicopathological evaluation of 60 cases // Eur. J. Gynaecol. Oncol. — 1994. - Vol.15. — P. 320.
15. Bagley C.M., Young R. С., Schein P. S., Chabner B. A., DeVitaV.T. Ovarian carcinoma metastatic to the diaphragm: frequently undiagnosed at laparotomy // J. Obstet. Gynecol. — 1973.- Vol. 116.—P. 397.
16. Bertelsen К., Holund В., Andersen J. Е., et al. Prognostic factors and adjuvant treatment in early epithelial ovarian cancer // Int. J. Gynecol. Cancer. — 1993. - Vol. 3. — P. 211.
17. BIythe J. G., Wahl T. P. Debulking surgery: does it increase the quality of survival? // Gynecol. Oncol. — 1982.- Vol. 14.—P. 396.
18. Bourne Т. Н., Campbell S., Reynolds K. М., et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and color blood flow imaging // Br. Med. J. — 1993. - Vol.306.-P. 1025.
19. Broders А. С. Grading and clinical application // Arch. Pathol. — 1976. - Vol. 2. — P. 376.
20. Campbell S., Bhan V., Royston P., Whitehead М. I., Collins W. P. Transabdominal ultrasound screening for early ovarian cancer // Br. Med. J. — 1989. - Vol. 299. — P. 1363.
21. Cancer Incidence in Five Continents // 1ARC Sci. Publ. — Lyon, 1997. - Vol. 7.
22. Cancer: Principles and Practice of Oncology. — 5th ed. / Ed. by V. T. DeVita, S. Hellman, S. A. Rosenberg. —NY: Lippincott Raven, 1997.
23. Carlson K. J., Skates S. J., Singer D. Е. Screening for ovarian cancer // Ann. Intern. Med. — 1994.- Vol. 121.—P. 124.
24 Cassagrande J. Т., Pike М. C., Russ R. K., Louie Е. W., Roy S., Henderson B. Е. Incessant ovulation and ovarian cancer// Lancet. — 1979. - Vol. 2. — P. 170.
25 Chambers J. Т., Chambers S. K., Voyneck 1. М., Schwartz P. Е. Neoadjuvant chemotherapy in stage X ovarian carcinoma // Gynecol. Oncol. — 1990. - Vol. 37. — P. 327.
26. Childers J. М., Lang J., Surwit Е. A., Hatch K. D. Laparoscopic surgical staging of ovarian cancer// Gynecol. Oncol. — 1995. - Vol. 59. — P. 25.
27. Colombo N., Sessa C., Landoni F., et al. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumors of the ovary // Obstet. Gynecol. — 1986. - Vol. 67. — P. 265.
28. Delgado G., Chun В., Caglar Н., et al. Para-aortic lymphadenectomy in gynecologic malignancies confined to the pelvis // Obstet. Gynecol. — 1978. - Vol. 50. — P. 418.
29. Dembo A. J., Bush R. S., Beale F., et al. Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation // Am. J. Obstet. Gynecol. — 1979. - Vol. 134, № 7. — P. 793-800.
30. DePriest P. D., Varner Е., Powell J., et al. The efficacy of sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation // Gynecol. Oncol. — 1994. - Vol.55.-P. 174.
31. Einchom L. Н., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer // Ann. Intern. Med. — 1977. - Vol. 87. — P. 293.
32. Einhorn N., Sjovall K., Knapp R. C., et al. Prospective evaluation of serum CA-125 levels for early detection of ovarian cancer // Obstet. Gynecol. — 1992. - Vol. 80. — P. 14.
33. Eisenkop S. М., Spirtos N. М., Montag Т. W., Nalick R. Н., Wang Н. J. The impact of sub-specialty training on the management of advanced ovarian cancer // Gynecol. Oncol. — 1992. - Vol.47.-P.203.
34. Farrow D. C., Weiss N. S., Lyon J. L., Daling J. R. Association of obesity and ovarian cancer in a case-control study//Am. J. Epidemiol.— 1989.- Vol. 129, №6.—P. 1300-1304.
35. Fathalla M. F. Incessant ovulation-9 factor in ovarian neoplasia// Lancet. — 1971. - Vol. 2. —P.163.
36. Greene M. Н., dark J. W., Blayney D. W. The epidemiology of ovarian cancer // Semin. Oncol. — 1984. - Vol. 11. — P. 209.
37. Gross T. P., Schlesselman J. J. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer // Obstet. Gynecol. — 1994. - Vol. 83. — P. 419.
38. Guthrie D., Davy M. L. J., Philips P. R. Study of 656 patients with early ovarian cancer // Gynecol. Oncol. — 1984. - Vol. 17, № 3. — Р. 363-369.
39. Harper P. A. Randomized comparison of Paclitaxel (T) and Carboplatin (J) versus a control arm of single agent Carboplatin (J) or CAP (cyclophosphamide, Doxorubicin and Cisplatin): 2075 patients randomized into the 3rd International Collaborative Ovarian Neoplasm Study (ICON3) // ASCO. — 1999. — Abst. № 128.
40. Hoskins W. J., Bundy B. N., Thigpen J. Т., Omura G. A. The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study // Gynecol. Oncol. — 1992. - Vol. 47. — P. 159.
41. Jacobs I., DaviesA.P., Bridges J., et al. Prevalence screening for ovarian cancer in post-menopausal women by CA-125 measurement and ultrasonography // Br. Med. J. — 1993. - Vol.306.-P. 1030.
42. Knapp R. C., Friedman Е. A. Aortic lymph node metastases in early ovarian cancer // Am. J. Obstet. Gynecol. — 1974.- Vol. 119.—P. 1013.
43. Kramer В. S., Gohagan J., Prorok P. С., Smart С. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers // Cancer. — 1993. - Vol.71.-P.589.
44. Kurjak A., Shalan H., Kupesic S., et al. An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography // J. Ultrasound Med. — 1994. - Vol. 13. — P. 295.
45. Longo D. L., Young R. C. Cosmetic talc and ovarian cancer // Lancet. — 1979. - Vol. 2. — P. 349.
46. Lynch H. Т., Kimberling W., Albano W. A., et al. Hereditary nonpolyposis colorectal cancer (C Lynch syndrome 1 and II): I clinical description of resource // Cancer. — 1985. - Vol. 56. — P. 934.
47. MalstromH., HogbergT., Risberg В., Simonson E. Granulosa cell tumors of the ovary: prognostic factors and outcome // Gynecol. Oncol. — 1994. - Vol. 52. — P. 50.
48. Markman M., Lewis J. L., Saigo P., et al. Impact of age on survival of patients with ovarian cancer // Gynecol. Oncol. — 1993. - Vol.
49. — P. 236. 49. Mayer A. R., Chambers S. К., Graves E., et al. Ovarian cancer staging: does it require a gy-necologic oncologist? // Gynecol. Oncol. — 1992. - Vol. 47. — P. 223.
50. McGuire W. P., Hoskins W. J., Brady M. P., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage 111 and stage IV ovarian cancer // N. Engl. J. Med. — 1996. - Vol. 334, № 1. — Р. 1-6.
51. McGuire W. P. Current aspects of adjuvant therapy of early stage ovarian cancer // Zentralbl. Gynakol. — 1998. — Bd. 120. — S. 93.
52. McGuire W. P., Hoskins W. J., Brady M. F., et al. Long-term follow up ofGOG 111: A randomized trial comparing cisplatin combined with Cyclophosphamide or paclitaxel in patients with stage III or IV epithelial ovarian cancer // Inter. J. Gynec. Cancer. — 1999. - Vol. 9. — P. 8.
53. Nguyen H. N., Averette H. E., Hoskins W., Penalver M., Sevin B. U., Steren A. National survey of ovarian carcinoma. V. The impact of physicians specialty on patients survival // Cancer. — 1993. - Vol. 72. — P. 3663.
54. Omura G. A., Brody M. F., Homesley H. D., et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinomas: the Gynecologic Oncology Group experience // J. Clin. Oncol. — 1991. - Vol. 9. — P. 1138.
55. Ozols R. F., Fisher R. I., Anderson Т., Makuch R., Young R. C. Peritoneoscopy in the management of ovarian cancer//Am. J. Obstet. Gynecol. — 1981. - Vol. 140. —№611.
56. Ozols R. F. Chemotherapy for ovarian cancer // Seminars of Oncology. — 1999. - Vol. 26. —P. 14.
57. Ozols R. F., Garvin J., Costa J., et al. Advanced ovarian cancer correlation of histologic grade with response to therapy and survival // Cancer. — 1980. - Vol. 45. — P. 572.
58. Ozols R. F., Rubin S. C., Dembo A. J., Robboy S. J. Epithelial ovarian cancer // Principles and practice of gynecologic oncology / Eds. W. J. Hoskins et al. — Philadelphia: JP Lippin-cott, 1992.—P. 731.
59. Pectasides D., Alevizakos N., Athanassiou A. E. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary // Ann. Oncol. — 1992. - Vol. 3. — Р. 316.
60. PiverM.S., Baker T. R., Piedmonte M., Sandecki A. M. Epidemiology and etiology of ovarian cancer//Cancer. Semin. Oncol. — 1991. - Vol. 18. — P. 177.
61. PiverM.S., Barlow J. J., Leie S. B. Incidence of subclinical metastasis in stage 1 and II ovarian carcinoma // Obstet. Gynecol. — 1978. - Vol. 52. — P. 100.
62. Ramarkrismhan S., Xu F. J., Brant S. J., et al. Elevated levels of macrophage colony stimulating factor (M-CSF) in serum and ascites from patients with epithelial ovarian cancer // Proc. Soc. Gynecol. Oncol. — 1990. - Vol. 21. — P. 40.
63. Rossing M A., Daling J. R., Weiss N. S., et al. Ovarian tumors in a cohort of infertile women//KEngl.J.Med.—1994.-VoL331.—P.771.
64 Roush G. R., EI-Naggar A. K.., Abdul-Karim F. W. Granulosa cell tumor of the ovary: a clinicopathologic flow cytometric DNA analysis // Gynecol. Oncol. — 1995. - Vol. 56. — P. 430.
65 Rustin G. J. S., Nelstrop A. E., Bentzen S. M., et al. Use of tumour markers in monitoring the ovarian cancer//Annals of Oncology.— 1999.- Vol. 10(Suppl. 1).—P.21-27.
66 Schapira M. M., Matchar D. В., Young M. J. The effectiveness of ovarian cancer screening. A decision analysis model // Ann. Intern. Med. — 1993. - Vol. 118, № 11. — P. 838-843.
67. Schwartz P. E., Chambers J. Т., Makuch R. Neoadjuvant chemotherapy for advanced ovarian cancer // Gynecol. Oncol. — 1994. - Vol. 53. — P. 33.
68. Schwartz P. E., Smith J. Management of ovarian stromal tumors // Am. J. Obstet. Gynecol. — 1976. - Vol. 125. — Р. 402.
69. Serov S. F., Scully R. E., Sobin L. H. International histologic classification and staging of tumors: no. 9 histologic typing of ovarian tumors. — Geneva: World Health Organization, 1973.
70. Simmons R. L., Sciarra J. J. Treatment of late recurrent granulosa cell tumors of the ovary // Surg. Gynecol. Obstet. — 1967. - Vol. 124. — P. 65.
71. Slattery M. L., Schuman K. L., West D. W., French J. K., Robison L. M. Nutrient intake and ovarian cancer // Am. J. Epidemiol. — 1989. - Vol. 130. — P. 497.
72. Smith J. P., Rutledge F. Advances in chemotherapy for gynecologic cancer // Cancer. — 1975.- Vol.36.—P. 669. 73. Struewing J. P., Watson P., Easton D. F., et al. Effectiveness of prophylactic oophorectomy in inherited breast/ovarian cancer families: Abstract // Am. J. Human Genet. — 1994. — №55.—P. 384.
74. Survival of Cancer Patients in Europe: Eurocare 2 Study // IARC Sci. Publ. — Lyon, 1999. —P.151.
75. Talerman A. Germ cell tumors of the ovary // Blaustein's pathology of the female genital tract / Ed. Kurman R. J. — 4th ed. — NY: Springer-Verlag, 1994. — P. 849.
76. Teneriello M. G., Ebina M., Linnoila R. I., et al. P53, Ki-ras gene mutations in epithelial ovarian neoplasms // Cancer Res. — 1993. - Vol. 53. — P. 3103.
77. Tewari K., Cappuccini F., Disaia P., et al. Malignant germ cell tumors of the ovary // Obstet. Gynecol. — 2000. - Vol. 95. — P. 128.
78. Thanikasalam K., HoC.M., AdeedN., Shahidan M. N., Azizah W. K. Patterns of ovarian tumors among Malaysian women at General Hospital, Kuala Lumpur // Med. J. Malaysia. — 1992.-Vol.47.-P.853.
79. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Epithelial ovarian cancer and combined oral contraceptives // Int. J. Epidemiol. — 1989. - Vol. 18. — P. 538.
80. The ICON Collaborators. ICON2: randomized trial of single-agent carboplatin against three-drug combination of CAP (Cyclophosphamide, doxorubici and cis-platin) in women with ovarian cancer // Lancet. — 1998. - Vol. 352. — Р. 1571.
81. TNM Классификация злокачественных опухолей. — 5-е изд. — СПб.: Эскулап, 1998. —190с.
82. Trebeck С. E., Friedlander M. 0., Russell P., Baird P. J. Brenner tumors of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline, and malignant ovarian tumors // Pathology. — 1987. - Vol. 19. — P. 241.
83. Trimble E. L., Trimble С. L. Epithelial ovarian tumors of low malignant potential // Cancer of the ovary / Eds. M. Markman, W. J. Hoskins. —NY: Raven Press, 1993.
84. Trope С., Piccart M. J., Stuart G., et al. Improved survival with paclitaxel-cisplatin compared with cyclophosphamide-cisplatin in advanced ovarian cancer after a median follow-up of 39 months: update of the EORTC, NOCOVA, NC1C, Scottish Intergroup Study // Int. J. Gyne-col. Cancer. — 1999. - Vol. 9. — P. 57.
85. Van der Burg M. E., van Lent M., Buyse M., et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. GCCG of EORTC // N. Engl. J. Med. — 1995. - Vol. 332. — P. 629.
86. Vergote I. В., Vergote-de Vos L. N., Abeler V. M., et al. Randomized trial comparing cis-platin with radioactive phosphorous or whole-abdomen irradiation as adjuvant treatment of ovarian cancer // Cancer. — 1992. - Vol. 69. — Р. 741.
87. Whittemore A. S. The risk of ovarian cancer after treatment for infertility // N. Engl. J. Med. — 1994. - Vol. 331. — P. 805.
88. WilIemsen W., Kruitwagen R., Bastiaans В., HanselaarT., Rolland R. Ovarian stimulation and granulosa-cell tumour // Lancet.— 1993. - Vol. 341.—P. 986.
89. Williams S., Blessing J. A., Liao S. Y., Ball H., Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the gynecologic oncology group // J. Clin. Oncol. — 1994. - Vol. 12. — P. 701.
90. Williams S. D., Birch R., Einhom L., et al. Disseminated germ cell tumors: chemotherapy with cisplatin plus bleomycin plus either vinblastine or etoposide // N. Engl. J. Med. — 1987. - Vol.316.-P. 1435.
91. Williams S. D., Blessing J. A., Moore D. H., Homesley H. D., Adcock L. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors // Ann. Intern. Med. —1989.- Vol. 111.—P.22.
92. Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality//Cancer. — 1993.-Vol.71.-P.517.
93. Young R. C., Walton L. A., Ellenberg S. S., et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomized trials // N. Engl. J. Med. — 1990.-Vol.322.-P. 1021.
94. Young R. H., Gilks С. В., Scully R. E. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei // Am. J. Surg. Pathol. — 1991. - Vol. 15.—P. 415.
95. Young R. C., Pecorelly S. Management of early ovarian cancer // Sem. Oncol. — 1998. - Vol. 25. — P. 335.
96. Zheng J., Benedict W. F., Xu H. J., et al. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas // J. Natl. Cancer Inst. — 1995.-Vol.87.-P. 1146.
